India · Delayed Price · Currency is INR Jenburkt Pharmaceuticals Statistics
Total Valuation
BOM:524731 has a market cap or net worth of INR 5.08 billion. The enterprise value is 4.57 billion.
| Market Cap | 5.08B |
| Enterprise Value | 4.57B |
Important Dates
The last earnings date was Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
BOM:524731 has 4.41 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 4.41M |
| Shares Outstanding | 4.41M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 55.12% |
| Owned by Institutions (%) | 1.19% |
| Float | 1.26M |
Valuation Ratios
The trailing PE ratio is 14.62.
| PE Ratio | 14.62 |
| Forward PE | n/a |
| PS Ratio | 2.84 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.58 |
| P/FCF Ratio | 39.67 |
| P/OCF Ratio | 19.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.46, with an EV/FCF ratio of 35.71.
| EV / Earnings | 13.17 |
| EV / Sales | 2.55 |
| EV / EBITDA | 8.46 |
| EV / EBIT | 8.98 |
| EV / FCF | 35.71 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.11 |
| Quick Ratio | 3.35 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.19 |
| Interest Coverage | 110.24 |
Financial Efficiency
Return on equity (ROE) is 18.84% and return on invested capital (ROIC) is 23.67%.
| Return on Equity (ROE) | 18.84% |
| Return on Assets (ROA) | 15.08% |
| Return on Invested Capital (ROIC) | 23.67% |
| Return on Capital Employed (ROCE) | 25.11% |
| Weighted Average Cost of Capital (WACC) | 6.19% |
| Revenue Per Employee | 2.30M |
| Profits Per Employee | 445,905 |
| Employee Count | 779 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 2.87 |
Taxes
In the past 12 months, BOM:524731 has paid 117.83 million in taxes.
| Income Tax | 117.83M |
| Effective Tax Rate | 25.33% |
Stock Price Statistics
The stock price has increased by +7.91% in the last 52 weeks. The beta is 0.35, so BOM:524731's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +7.91% |
| 50-Day Moving Average | 1,023.50 |
| 200-Day Moving Average | 1,109.23 |
| Relative Strength Index (RSI) | 71.84 |
| Average Volume (20 Days) | 1,704 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524731 had revenue of INR 1.79 billion and earned 347.36 million in profits. Earnings per share was 78.71.
| Revenue | 1.79B |
| Gross Profit | 1.47B |
| Operating Income | 509.32M |
| Pretax Income | 465.19M |
| Net Income | 347.36M |
| EBITDA | 540.40M |
| EBIT | 509.32M |
| Earnings Per Share (EPS) | 78.71 |
Balance Sheet
The company has 531.15 million in cash and 24.88 million in debt, with a net cash position of 506.26 million or 114.71 per share.
| Cash & Cash Equivalents | 531.15M |
| Total Debt | 24.88M |
| Net Cash | 506.26M |
| Net Cash Per Share | 114.71 |
| Equity (Book Value) | 1.97B |
| Book Value Per Share | 446.40 |
| Working Capital | 719.43M |
Cash Flow
In the last 12 months, operating cash flow was 265.22 million and capital expenditures -137.17 million, giving a free cash flow of 128.05 million.
| Operating Cash Flow | 265.22M |
| Capital Expenditures | -137.17M |
| Depreciation & Amortization | 31.08M |
| Net Borrowing | -6.40M |
| Free Cash Flow | 128.05M |
| FCF Per Share | 29.01 |
Margins
Gross margin is 81.94%, with operating and profit margins of 28.45% and 19.40%.
| Gross Margin | 81.94% |
| Operating Margin | 28.45% |
| Pretax Margin | 25.98% |
| Profit Margin | 19.40% |
| EBITDA Margin | 30.18% |
| EBIT Margin | 28.45% |
| FCF Margin | 7.15% |
Dividends & Yields
This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 1.68%.
| Dividend Per Share | 18.00 |
| Dividend Yield | 1.68% |
| Dividend Growth (YoY) | 17.65% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 22.86% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 1.68% |
| Earnings Yield | 6.84% |
| FCF Yield | 2.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |